Citation:
Abdalla, E. K., Eng, C., Madary, A., & Vauthey, J. N. (2006). Southwest Oncology Group 0408: Phase II trial of neoadjuvant capecitabine/oxaliplatin/bevacizumab for resectable colorectal metastases in the liver. Clinical colorectal cancer, 5(6), 436-438.